Managers / Q1 2021 · view latest →
Stenham Asset Management Ltd
CIK 0001840750 · KINGSWAY HOUSE HAVILLAND STREET, ST PETER PORT, GUERNSEY, GY1 2QE · 00441481716387
Summary
Stenham Asset Management Ltd reported $142M in U.S.-listed holdings across 26 positions for Q1 2021.
Its largest position, TSM, represents 16.0% of the portfolio.
Compared with Q4 2020, the fund opened 6 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 70.5% · $100M
- ADR · 16.0% · $23M
- REIT · 7.7% · $11M
- Other · 4.5% · $6M
- ETP · 0.7% · $1M
- Other · 0.6% · $806,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| COSTCOSTCO WHSL CORP NEW | NEW | +18.0K | 18.0K | +$6M | $6M |
| ADSKAUTODESK INC | NEW | +22.0K | 22.0K | +$6M | $6M |
| EPIEURESSA PHARMA INC | NEW | +147.1K | 147.1K | +$4M | $4M |
| SCORE MEDIA & GAMING INC | NEW | +145.0K | 145.0K | +$4M | $4M |
| FATEFATE THERAPEUTICS INC | NEW | +33.9K | 33.9K | +$3M | $3M |
| 2JQGRITSTONE ONCOLOGY INC | NEW | +150.0K | 150.0K | +$1M | $1M |
| MSCIMSCI INC | SOLD OUT | −12.0K | 0 | −$5M | $0 |
| ZYMEUSDZYMEWORKS INC | SOLD OUT | −50.0K | 0 | −$2M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $206M | 18 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $200M | 23 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $174M | 21 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $229M | 24 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $246M | 28 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $153M | 22 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $153M | 24 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $163M | 26 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $142M | 26 | May 7, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $119M | 23 | Feb 2, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.